SOPHiA GENETICS (SOPH) Operating Leases (2020 - 2026)

SOPHiA GENETICS has disclosed Operating Leases across 7 years of filings, most recently posting $11.1 million for Q2 2026.

• In Q2 2026, Operating Leases fell 19.87% year-over-year to $11.1 million; the TTM figure through Jun 2026 stood at $11.1 million (down 19.87% YoY), while the FY2025 annual figure was $12.6 million, down 13.81% from the prior year.
• Operating Leases came in at $11.1 million for Q2 2026 at SOPHiA GENETICS, down from $11.9 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $16.7 million in Q4 2022 to a low of $10.7 million in Q1 2022.
• Average Operating Leases over 5 years is $14.1 million, with a median of $14.6 million recorded in 2024.
• Year-over-year, Operating Leases soared 539.93% in 2022 and fell 19.87% in 2026.
• Over 5 years, Operating Leases stood at $16.7 million in 2022, then declined by 6.39% to $15.7 million in 2023, then slipped by 6.83% to $14.6 million in 2024, then declined by 13.81% to $12.6 million in 2025, then dropped by 11.75% to $11.1 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $11.1 million in Q2 2026, $11.9 million in Q1 2026, and $12.6 million in Q4 2025.